Incidence of Thromboembolic Complications Following Kidney Transplantation with Short and Extended Aspirin Prophylaxis: A Retrospective Single-Center Study

被引:1
作者
Pegler, Angus H. [1 ]
Hegerty, Katharine [1 ]
Gately, Ryan P. [1 ,2 ]
Hawley, Carmel M. [1 ,2 ]
Johnson, David W. [1 ,2 ,3 ]
Cho, Yeoungjee [1 ,2 ]
Jegatheesan, Dev K. [1 ,2 ]
McCann, Andrew B. [4 ]
Harfield, Michelle E. [1 ,5 ]
Isbel, Nicole M. [1 ,2 ,3 ]
机构
[1] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia
[2] Univ Queensland, Australasian Kidney Trials Network, Brisbane, Qld, Australia
[3] Translat Res Inst, Brisbane, Qld, Australia
[4] Princess Alexandra Hosp, Dept Vasc Med, Brisbane, Qld, Australia
[5] Townsville Univ Hosp, Dept Nephrol, Townsville, Qld, Australia
关键词
Antilymphocyte Serum; Aspirin; Cardiovascular Diseases; Kidney Transplantation; Renal Insufficiency; Venous Thromboembolism; LOW-DOSE ASPIRIN; RISK; WITHDRAWAL; THROMBOSIS; THERAPY; EVENTS;
D O I
10.12659/AOT.939143
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Aspirin prophylaxis has been associated with reduced graft-related thrombosis following kidney transplanta-tion. Aspirin cessation, however, can increase risk of venous thromboembolic complications, including pulmo-nary thromboembolism and deep venous thrombosis. This single-center, retrospective, pre-post intervention-al study from Brisbane, Australia, aimed to compare the rate of thrombotic complications in 1208 adult kidney transplant recipients receiving postoperative aspirin for 5 days or >6 weeks. Material/Methods: We enrolled1208 kidney transplant recipients who received 100 mg aspirin for 5 days (n=571) or >6 weeks (n=637) postoperatively. The primary outcome was venous thromboembolism (VTE) in the first 6 weeks after transplant, examined by multivariable logistic regression analysis. Secondary outcomes were renal vein/artery thrombosis, 1-month serum creatinine, rejection, myocardial infarction, stroke, blood transfusion, dialysis at day 5 and day 28, and mortality.Results: Sixteen (1.3%) patients experienced VTE (5-day n=8, 1.4%; >6-week n=8, 1.3%; P=0.8). Extended aspirin dura-tion was not independently associated with a reduction in VTE (OR 0.91, 95% CI 0.32-2.57; P=0.9). Graft throm-bosis was rare (n=3, 0.25%). Aspirin duration was not associated with cardiovascular events, blood transfu-sion, graft thrombosis, graft dysfunction, rejection, or mortality. VTE was independently associated with older age (OR 1.09, 95% CI 1.04-1.16; P=0.002), smoking (OR 3.59, 95% CI 1.20-13.2; P=0.032), younger donor age (OR 0.96, 95% CI 0.93-1.00; P=0.036), and thymoglobulin use (OR 10.5, 95% CI 3.09-32.1; P & POUND;0.001). Conclusions: Extended-duration aspirin use did not significantly reduce the incidence of VTE in the first 6 weeks following kidney transplantation. An association was identified between anti-human thymocyte immunoglobulin and VTE, which requires further assessment.
引用
收藏
页数:10
相关论文
共 26 条
[1]   The rebound phenomenon after aspirin cessation: The biochemical evidence [J].
Alcock, Richard F. ;
Reddel, Caroline J. ;
Pennings, Gabrielle J. ;
Hillis, Graham S. ;
Curnow, Jennifer L. ;
Brieger, David B. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 174 (02) :376-378
[2]  
[Anonymous], 2010, LANG ENV STAT COMP
[3]  
ANZDATA, 2020, 43 REP CHAPT 7 KIDN
[4]   Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment [J].
Beving, H ;
Zhao, C ;
Albage, A ;
Ivert, T .
BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (01) :80-84
[5]   A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease [J].
Biondi-Zoccai, Giuseppe G. L. ;
Lotrionte, Marzia ;
Agostoni, Pierfrancesco ;
Abbate, Antonio ;
Fusaro, Massimiliano ;
Burzotta, Francesco ;
Testa, Luca ;
Sheiban, Imad ;
Sangiorgi, Giuseppe .
EUROPEAN HEART JOURNAL, 2006, 27 (22) :2667-2674
[6]   Low-dose aspirin for secondary cardiovascular prevention -: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation -: review and meta-analysis [J].
Burger, W ;
Chemnitius, JM ;
Kneissl, GD ;
Rücker, G .
JOURNAL OF INTERNAL MEDICINE, 2005, 257 (05) :399-414
[7]  
Cheungpasitporn Wisit, 2017, J Nephropathol, V6, P110, DOI 10.15171/jnp.2017.19
[8]   Prophylaxis of Pulmonary Embolism in Kidney Transplant Recipients [J].
Cicora, Federico ;
Petroni, Jorgelina ;
Roberti, Javier .
CURRENT UROLOGY REPORTS, 2018, 19 (02)
[9]  
Cundiff David Keith, 2008, Medscape J Med, V10, P258
[10]   Aspirin in Patients Undergoing Noncardiac Surgery [J].
Devereaux, P. J. ;
Mrkobrada, M. ;
Sessler, D. I. ;
Leslie, K. ;
Alonso-Coello, P. ;
Kurz, A. ;
Villar, J. C. ;
Sigamani, A. ;
Biccard, B. M. ;
Meyhoff, C. S. ;
Parlow, J. L. ;
Guyatt, G. ;
Robinson, A. ;
Garg, A. X. ;
Rodseth, R. N. ;
Botto, F. ;
Buse, G. Lurati ;
Xavier, D. ;
Chan, M. T. V. ;
Tiboni, M. ;
Cook, D. ;
Kumar, P. A. ;
Forget, P. ;
Malaga, G. ;
Fleischmann, E. ;
Amir, M. ;
Eikelboom, J. ;
Mizera, R. ;
Torres, D. ;
Wang, C. Y. ;
VanHelder, T. ;
Paniagua, P. ;
Berwanger, O. ;
Srinathan, S. ;
Graham, M. ;
Pasin, L. ;
Le Manach, Y. ;
Gao, P. ;
Pogue, J. ;
Whitlock, R. ;
Lamy, A. ;
Kearon, C. ;
Baigent, C. ;
Chow, C. ;
Pettit, S. ;
Chrolavicius, S. ;
Yusuf, S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (16) :1494-1503